Cambridge Investment Research Advisors, Inc. Spdr Series Tr Spdr S&P Homebu Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Spdr Series Tr Spdr S&P Homebu stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 22,295 shares of XHB stock, worth $2.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,295

Previous 55,321 59.7%

Holding current value

$2.24 Million

Previous $6.89 Million 66.19%

% of portfolio

0.01%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.5 - $125.64 $3.45 Million - $4.15 Million	-33,026 Reduced 59.7%	22,295 $2.33 Million
Q3 2024 Oct 28, 2024	BUY	$97.96 - $124.99 $3.13 Million - $3.99 Million	31,926 Added 136.47%	55,321 $6.89 Million
Q2 2024 Jul 26, 2024	SELL	$100.16 - $110.14 $3.9 Million - $4.29 Million	-38,908 Reduced 62.45%	23,395 $2.37 Million
Q1 2024 Apr 24, 2024	BUY	$91.71 - $111.59 $3.25 Million - $3.95 Million	35,390 Added 131.5%	62,303 $6.95 Million
Q4 2023 Feb 09, 2024	SELL	$69.36 - $96.47 $2.46 Million - $3.42 Million	-35,477 Reduced 56.86%	26,913 $2.57 Million
Q3 2023 Oct 24, 2023	SELL	$75.64 - $85.02 $946,256 - $1.06 Million	-12,510 Reduced 16.7%	62,390 $4.78 Million
Q2 2023 Jul 13, 2023	BUY	$64.48 - $80.3 $3.24 Million - $4.04 Million	50,302 Added 204.5%	74,900 $6.01 Million
Q1 2023 May 11, 2023	BUY	$61.13 - $72.27 $545,340 - $644,720	8,921 Added 56.91%	24,598 $1.67 Million
Q4 2022 Feb 08, 2023	SELL	$53.4 - $63.29 $150,534 - $178,414	-2,819 Reduced 15.24%	15,677 $946,000
Q3 2022 Oct 17, 2022	SELL	$53.98 - $67.45 $107,204 - $133,955	-1,986 Reduced 9.7%	18,496 $0
Q2 2022 Jul 13, 2022	BUY	$52.03 - $65.46 $120,917 - $152,129	2,324 Added 12.8%	20,482 $0
Q1 2022 May 12, 2022	SELL	$63.2 - $85.09 $766,742 - $1.03 Million	-12,132 Reduced 40.05%	18,158 $0
Q4 2021 Feb 03, 2022	BUY	$71.78 - $86.27 $758,283 - $911,356	10,564 Added 53.55%	30,290 $0
Q3 2021 Nov 02, 2021	SELL	$70.21 - $78.88 $66,629 - $74,857	-949 Reduced 4.59%	19,726 $0
Q2 2021 Aug 10, 2021	SELL	$70.13 - $79.38 $3.35 Million - $3.79 Million	-47,703 Reduced 69.76%	20,675 $0
Q1 2021 May 07, 2021	BUY	$56.77 - $70.84 $2.8 Million - $3.49 Million	49,265 Added 257.76%	68,378 $0
Q4 2020 Feb 04, 2021	SELL	$51.98 - $59.41 $2 Million - $2.29 Million	-38,547 Reduced 66.85%	19,113 $0
Q3 2020 Oct 29, 2020	BUY	$43.25 - $54.31 $1.75 Million - $2.2 Million	40,491 Added 235.84%	57,660 $0
Q2 2020 Jul 27, 2020	BUY	$26.48 - $45.69 $200,374 - $345,736	7,567 Added 78.81%	17,169 $0
Q1 2020 May 08, 2020	BUY	$24.72 - $49.23 $81,378 - $162,065	3,292 Added 52.17%	9,602 $0
Q4 2019 Feb 04, 2020	SELL	$42.76 - $46.42 $3.06 Million - $3.32 Million	-71,562 Reduced 91.9%	6,310 $0
Q3 2019 Nov 06, 2019	BUY	$42.79 - $44.08 $3.05 Million - $3.14 Million	71,277 Added 1080.77%	77,872 $0
Q2 2019 Aug 15, 2019	SELL	N/A	-1,302 Reduced 16.49%	6,595 $0
Q1 2019 May 08, 2019	SELL	N/A	-328 Reduced 3.99%	7,897 $0
Q4 2018 Feb 05, 2019	SELL	N/A	-504 Reduced 5.77%	8,225 $0
Q3 2018 Nov 02, 2018	BUY	N/A	113 Added 1.31%	8,729 $0
Q2 2018 Aug 10, 2018	SELL	N/A	-6,295 Reduced 42.22%	8,616 $0
Q1 2018 May 09, 2018	BUY	N/A	1,573 Added 11.79%	14,911 $0
Q4 2017 Feb 22, 2018	BUY	N/A	3,080 Added 30.03%	13,338 $0
Q3 2017 Nov 07, 2017	SELL	N/A	-30,365 Reduced 74.75%	10,258 $408,000
Q2 2017 Aug 08, 2017	BUY	N/A	40,623	40,623 $1.57 Million

Others Institutions Holding XHB

# of Institutions

380

Shares Held

18.4M

Call Options Held

2.44M

Put Options Held

5.57M

View Full List

About SPDR SERIES TR SPDR S&P HOMEBU

Ticker XHB
Sector ETFs
Industry ETFs

More about XHB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Spdr Series Tr Spdr S&P Homebu Transaction History